HuagongsheHuagongshe Chemistry Print Report · For research reference only
Methyl morpholine oxide → 2-Bromoimidazo[5,1-b]thiazole-7-carbaldehyde
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | 2-Bromo-7-hydroxymethylimidazo[5,1-b]thiazole | HCID 59168406 | — |
| Catalyst | HCID 178419074 | HCID 178419074 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 2-Bromoimidazo[5,1-b]thiazole-7-carbaldehyde | HCID 11528744 | 21% |
Reaction Steps
Dried 4A molecular sieves (40 mg) and tetra-n-propylammonium perruthenate (16 mg, 0.05 mmol) were added to a solution of 2-bromo-7-hydroxymethylimidazo[5,1-b]thiazole (53 mg, 0.23 mmol) and N-methylmorpholine-N-oxide (92 mg, 0.79 mmol) in dichloromethane (2 ml), and the mixture was stirred at room temperature for 3 days. The reaction solution was purified by column chromatography on silica gel (ethyl acetate:methanol=60:1) to give 2-bromoimidazo[5,1-b]thiazole-7-carbaldehyde (11 mg, 21%) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07662841B2 |
| Source dataset | uspto-grants-2010_02 |
| ORD ID | ord-26e0f52d712142ab8df2a0f7f16a38df |
| Source note | uspto-grants-2010_02 |